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Abstract SOX10, a new member of the SOX gene family, is a
transcription factor defective in the Dom (Dominant megacolon)
mouse and in the human Shah-Waardenburg syndrome. To help
unravel its physiological role during human development, we
studied SOX10 gene expression in embryonic, fetal, and adult
human tissues by Northern blot and in situ hybridization. As in
mice, the human SOX10 gene was essentially expressed in the
neural crest derivatives that contribute to the formation of the
peripheral nervous system, and in the adult central nervous
system. Nevertheless, it was more widely expressed in humans
than in rodents. The spatial and temporal pattern of SOX10
expression supports an important function in neural crest
development.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The identi¢cation of the mammalian testis determination
factor SRY (sex determining region on the Y chromosome)
led to the description of the SOX (SRY box-containing)
gene family, a new class of genes coding for transcription
factors [1^3]. These genes are characterized by a DNA binding
domain similar to the high-mobility group (HMG) domain of
SRY [1,4,5]. The SOX genes are highly conserved through
evolution, and show diverse and changing patterns of expres-
sion throughout development. Some members play important
roles during embryonic stages, in segmentation, chondrogen-
esis, haematopoiesis and sex determination, and in the CNS
(central nervous system) development. They appear to govern
cell fate during embryogenesis by functioning both as classical
(co)transcription factors and as architectural components of
the chromatin [6]. The functional role of SOX genes in human
genetic diseases was demonstrated by the involvement of SRY
in XY sex reversal [7,8], and of SOX9 in campomelic dyspla-
sia [9^11], a dominantly inherited congenital osteochondro-
dysplasia associated in some instances with male to female
autosomal sex reversal.
Recently, a new member of this family, Sox10, was cloned
[12]. In mouse and rat, this gene seems to be selectively ex-
pressed in neural crest cells during early stages of develop-
ment, and in glial cells of the peripheral and central nervous
systems later in development and in adulthood. We and others
established that the defects observed in the spontaneous
mouse mutant Dominant megacolon (Dom), which displays
intestinal aganglionosis and depigmentation, are caused by a
Sox10 gene mutation [13,14]. We also showed that its human
homologue SOX10 is defective in some cases of the Shah-
Waardenburg syndrome (WS4) [15], a disease in which the
neurosensory deafness and pigmentation abnormalities usu-
ally seen in the Waardenburg syndrome are combined with
the aganglionic colon characteristic of Hirschsprung disease
[16]. These two syndromes have been causatively linked to
de¢cient migration/proliferation/di¡erentiation of neural crest
cells (neurocristopathies) [17].
To help unravel the physiological role of SOX10 during
human development, we studied SOX10 gene expression in
embryonic, fetal, and adult human tissues by Northern blot
and in situ hybridization.
2. Materials and methods
2.1. Northern blot analysis
Multiple tissue Northern blots (Clontech) were sequentially hybrid-
ized with a Q-32P (Amersham) labelled SOX10c oligonucleotide probe
(see Section 2.3) and a human L actin cDNA probe according to
the suppliers’ instructions. A 1.7-kb fragment corresponding to the
3P end of the SOX10 cDNA devoid of the HMG box (from nucleo-
tide 870, GenBank accession number AJ001183), was also used as a
probe.
2.2. In situ hybridization
Twelve morphologically normal human embryos (4 to 6 weeks of
development) were obtained from legal abortions induced by mifepri-
stone (RU486) at HoŒpital Broussais in Paris. Complete independence
was respected between the medical sta¡ and the research group. The
women’s consent was obtained after thorough explanation of the
planned research. All procedures were approved by the ethics com-
mittee of HoŒpital Necker-Enfants-Malades in Paris.
Embryo and slide preparations, and subsequent steps of in situ
hybridization, were performed as previously described [18]. The brain
of a 25-weeks-old fetus was obtained and treated in the same way.
Ten-micrometer-thick cryostat sections mounted on ProbeOn Plus
slides (Microm) were used. The probes were labelled with K-35S-
dATP (NEN) and puri¢ed on Biospin columns (Biorad) before hy-
bridization. Finally, slides were exposed to Hyper¢lm L max X-ray
¢lms (Amersham) for 7 days and then to Kodak NTB2 photographic
emulsion for 8 weeks at 4‡C.
2.3. In situ hybridization probes
60-mers oligonucleotide probes (Genset) were chosen in the 3P un-
translated region of human SOX10 cDNA (GenBank accession num-
ber AJ001183). The antisense probes SOX10c, SOX10d and SOX10j
have the following sequences: 5P-TCTTTCAGTGTGGGTGCAACA-
GTCAACCTCCTTCTCCTCTGTCCAGCCTGTTCTCCTGGG-3P
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(nucleotides 1776^1717), 5P-GATGAGAACTCCACTAAGTCCCTC-
GAACCCCCCACTCCCCAATGAGGCTCCTCAAAGCTA-3P (nu-
cleotides 2090^2031) and 5P-GATGCGTCTCAAGGTCATGGAG-
GTTGTAGTGGAGGAGGACTGGGGGCTGTTTCTCAGACA-3P
(nucleotides 2237^2178), respectively. Sense probes were used as neg-
ative controls.
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Fig. 1. Tissue distribution of SOX10 mRNA. Upper panel: Northern blots (Clontech) containing various fetal and adults tissues (A) or adult
human brain areas (B) hybridized with the oligonucleotide probe SOX10c. Lower panel: Integrity and equal loading of the RNAs were checked
by rehybridization with a L actin probe.
Fig. 2. Distribution of SOX10 mRNA in the human embryo. Parasagittal section of a 4-weeks-old (A, B) and sagittal section of a 6-weeks-old
(C, D) human embryo. A, C: Autoradiographic labelling after in situ hybridization using SOX10 oligonucleotide probes. B, D: Histological as-
pect of the same embryo sections (bright ¢eld). In each case, after observation of the in situ hybridization signals, sections were counterstained
again with hematoxylin and eosin. E: Putative caudal neural crest cells of a 4-weeks-old embryo (dark ¢eld). F: Sagittal section of a 6-weeks-
old embryo (bright ¢eld). G: Enlargement of box in F (dark ¢eld) showing no signal in the Rathke pouch and a di¡use signal identi¢ed as the
cephalic neural crest (mesectoderm). Cranial nerves and ganglia are shown in Roman numerals: V, trigeminal; VII, acoustico facial; IX, glosso-
pharyngeal; X, vagus. cnc, cephalic neural crest; drg, dorsal root ganglia; ncc, neural crest cells; ot, otic vesicle; rt, rathke pouch; rh, rhom-
bencephalon; sp, spinal nerves; tel, telencephalon. Arrowhead in A shows hybridization signal in migrating cells at the origin of the glossophar-
yngeal ganglia. Arrowhead in C shows spinal nerves pathway. Scale bar: A, B: 1.3 mm; C, D: 2 mm; E: 125 Wm; F: 1.4 mm; G: 446 Wm.
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3. Results
3.1. General tissue distribution of SOX10 mRNAs
SOX10 mRNA expression was ¢rst analyzed with Northern
blots containing a panel of fetal and adult tissues. Similar
results were obtained with the oligonucleotide probe
SOX10c (Fig. 1A) and the 1.7-kb partial cDNA probe (data
not shown). A major transcript of 3.1 kb was detected in
several tissues. In fetal tissues from 17 to 25 weeks of develop-
ment, SOX10 expression was essentially found in brain and,
to a lesser extent, in lung and kidney. In adult tissues, SOX10
was preferentially expressed in brain, colon, small intestine
and heart and, to a lesser extent, in prostate, bladder, pan-
creas and stomach. Interestingly, we detected a major tran-
script of approximately 2.7 kb in testis. In addition, a faint
5.3-kb band, the identity of which remains to be determined,
was present in most lanes.
3.2. SOX10 gene expression in adult and developing CNS
The detection of a strong SOX10 signal in whole fetal and
adult brain prompted us to undertake a detailed evaluation of
SOX10 gene expression in various adult brain areas by North-
ern blotting (Fig. 1B). SOX10 was expressed in each brain
region analyzed. However, the intensity of the signals varied
from one area to another. A high level of SOX10 gene tran-
scripts was seen in the spinal cord, medulla and corpus cal-
losum, while it was weaker in the cerebellum, occipital pole,
frontal lobe, amygdala and thalamus. Interestingly, SOX10
transcripts were detected in major brain nuclei such as the
subthalamic and caudate nuclei.
To gain more insight into SOX10 expression during devel-
opment, we performed in situ hybridization on human em-
bryos and fetal brain tissue sections. No signal was detected
with any of the sense probes used as negative controls. At
4 weeks of development, SOX10 hybridization signals were
¢rst detected both at the autoradiographic (Fig. 2A, B) and
cellular levels (Fig. 2E) between the neural tube and the so-
mites. This distribution is consistent with the presence of
SOX10 transcripts in putative neural crest cells. As embryonic
development proceeds this signal tended to fade. Throughout
the ¢rst 6 weeks of development, no SOX10 gene expression
was found in the central nervous system. In a 6-weeks-old
human embryo, no hybridization signal was detected in the
prosencephalon, mesencephalon, rhombencephalon, Rathke’s
pouch and posthypophysis (Fig. 2C, D, F, G).
During the fetal period, SOX10 autoradiographic in situ
hybridization signals started to be detected in the CNS. The
SOX10 gene was expressed in the brain at 25 weeks of devel-
opment. The strongest autoradiographic signals were observed
in the cerebral cortex and germinative zone. The hippocampal
formation and the thalamic nuclei showed weaker positive
hybridization signals (data not shown).
3.3. SOX10 gene expression in embryonic neural crest cell
derivatives
As previously mentioned, during early human development,
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Fig. 3. Expression of SOX10 in the peripheral nervous system. Dark-¢eld (A^E and G) and bright-¢eld (F) examination of sagittal sections of
6-weeks-old embryos. A, B: SOX10 expression was detected in the cranial ganglia and otic vesicle. A shows also signals in the dorsal root gan-
glia and spinal nerves. C: Dorsal root ganglia. D: Labelling of the sympathetic trunk. E, F: Corresponding dark- and bright-¢eld photomicro-
graphs showing labelling of the sympathetic trunk and cranial foregut derivatives. G: Putative enteric ganglia in a stomach section. Note the
SOX10 expression in the submandilar gland (A) and lung (E). Cranial nerves and ganglia are shown in Roman numerals: V, trigeminal; VII,
facial; VIII, acoustic; IX, glossopharyngeal; X, vagus. drg, dorsal root ganglia; fg, foregut; h, heart; L, lung; ot, otic vesicle; s; submandibu-
lar gland and lingual nerve; sp, spinal nerves; st, stomach; sym, sympathetic chain. Scale bar: A: 960 Wm; B: 320 Wm; C: 125 Wm; D: 384
Wm; E, F: 446 Wm; G: 320 Wm.
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SOX10 gene is expressed in neural crest cells. As human de-
velopment progresses, SOX10 becomes preferentially ex-
pressed in the neural crest derivatives which contribute to
the formation of the peripheral nervous system. All cranial
and spinal ganglia yielded a strong SOX10 in situ hybridiza-
tion signal as soon as they were formed. SOX10 signals were
also detected in some migrating cells giving rise to the glosso-
pharyngeal ganglia (Fig. 2A, B). Between the ¢fth and sixth
week of development all cranial ganglia and nerves, and the
otic vesicle, were intensely labelled at the autoradiographic
(Fig. 2C, D) and cellular levels (Fig. 3A, B). SOX10 was
strongly expressed in spinal nerves linked to dorsal root gan-
glia, and in dorsal root ganglia themselves (Fig. 3A, C). The
labelling of these nerves was detected not only along their
pathways but also in their terminal branches (Fig. 2C, D).
Interestingly, the entire sympathetic ganglia chain was
strongly labelled (Fig. 3D^F). SOX10 gene expression was
also observed in parasympathetic ganglia (data not shown).
Hybridization signals were detected in the digestive tract.
SOX10-positive cells were observed in the cranial foregut (Fig.
3E, F). In the oesophagus and stomach, positive cells were
found at the site of the putative enteric ganglia (Fig. 3G).
Di¡use positive signals corresponding to cephalic neural
crest derivatives (mesectoderm) were also detected (Fig. 2F,
G). These cephalic neural crest derivatives form cartilaginous
rudiments of several nasal bones.
SOX10 gene expression was found in the submandibulary
gland and lingual nerve (Fig. 3A), the foramen caecum at the
origin of the thyroid, the pancreas (data not shown) and the
lung (Fig. 3E, F). Up to 6 weeks of development, no signal
was detected in the heart, the future ectoderm or the pigmen-
tary epithelium of the retina.
4. Discussion
The identi¢cation of a new member of the SOX gene fam-
ily, Sox10 [12], and its involvement in the Shah-Waardenburg
syndrome [15] prompted us to study its expression pattern in
humans by Northern blotting and in situ hybridization.
In situ hybridization was performed on human embryos
from 4 to 6 weeks of development. This period encompasses
crucial processes of morphogenesis and organogenesis. During
this period, neural crest cells emerge from the neural tube,
migrate extensively, and form most elements of the peripheral
nervous system, as well as facial cartilage, pigment cells, and
neuroendocrine cells [19,20].
Our study clearly shows that, in the human embryo, the
SOX10 gene is expressed in neural crest cells, and as develop-
ment progresses, in their derivatives that give rise to the pe-
ripheral nervous system and cephalic mesectoderm. No
SOX10 in situ hybridization signal was observed in the em-
bryonic central nervous system.
SOX10 gene expression was ¢rst described in rodents [12].
During embryogenesis the expression pattern seems to be con-
served through evolution. However, a detailed analysis of
SOX10 signals shows slight di¡erences between humans and
rodents. Indeed, a key ¢nding of our work was the labelling of
cephalic neural crest cell derivatives (mesectoderm) giving rise
to cartilaginous rudiments of nasal bones.
Moreover SOX10 is more widely expressed in human fetal
and adult tissues than in rodents. In the CNS, strong SOX10
gene expression characterized several adult brain areas such as
the corpus callosum, medulla and spinal cord but, interest-
ingly, contrary to rodents, consistent SOX10 gene expression
was found in the human fetal and adult cerebral cortex and
major brain nuclei. It thus seems that SOX10 gene expression
is not restricted to glial cells in humans. Additional double-
labelling experiments are required to establish whether SOX10
is expressed in glial cells and/or neuronal cells.
Other noteworthy di¡erences in SOX10 gene expression be-
tween rodents and human tissues were observed. We detected
SOX10 gene transcripts in human adult heart, prostate and
testis by Northern blot analysis. The precise function of
SOX10 in these tissues is unknown, but neural crest cells
contribute to the organization of the out£ow septum and
form the cholinergic cardiac ganglia of the parasympathetic
plexus [21]. Interestingly, a smaller transcript was detected in
human adult testis. The variable size of the transcripts could
result from alternative splicing or from the use of di¡erent
promoters and/or polyadenylation signals. Alternative splicing
has been shown to generate SOX17 transcripts of various sizes
in adult mouse testis tissue [22], and a similar mechanism
might account for the shorter SOX10 transcripts observed
here.
Because of their transient and highly restricted tissue distri-
bution, several SOX factors are thought to function as genetic
switches that determine cell fate during embryogenesis [6]. In
contrast, the continuous expression of SOX10 during develop-
ment argues for a role in de¢ning and maintaining the cell
phenotype. As suggested in the case of the SOX22 gene, which
also shows a large spectrum of expression [23], SOX10 might
trans-regulate distinct pools of targets according to the tissues
in which it is expressed, most likely in conjunction with addi-
tional tissue-speci¢c factors.
SOX10 gene mutations have been identi¢ed in patients with
the Shah-Waardenburg syndrome [15], a disorder in which
two neural crest-derived cell lineages, melanocytes and intes-
tinal ganglia cells, are a¡ected. Our analysis of SOX10 gene
expression in the embryonic digestive tract (by in situ hybrid-
ization) and adult colon and small intestine (by Northern
blotting) is in keeping with the presence of SOX10 transcripts
in enteric ganglia. We observed no SOX10 hybridization sig-
nal in the epidermis throughout the ¢rst 6 weeks of develop-
ment. However, given that several human SOX10 ESTs derive
from skin melanocytes and that melanocytes enter the epider-
mis at 6 weeks of development, it is possible that the low level
of SOX10 transcripts precluded their detection at the stages
analyzed.
Two other genes, the Endothelin 3 (EDN3) and Endothelin
B receptor (EDNRB) genes, are involved in the Shah-Waar-
denburg syndrome [24,25]. It is noteworthy that the SOX10
and EDNRB genes have an overlapping and concomitant ex-
pression pattern in the peripheral nervous system during hu-
man embryogenesis [26], suggesting that they may act via a
common regulatory pathway.
In conclusion, the results reported here further support the
important function of SOX10 in neural crest development.
The observation that SOX10 is more widely expressed in hu-
mans than in rodents infers that SOX10 may have additional
roles in human development and physiology. If this is indeed
the case, some SOX10 mutations may give rise to other phe-
notypic features distinct from those of the Shah-Waardenburg
syndrome. Thus, detection of SOX10 defects may help deciph-
er the molecular basis of other neurocristopathies.
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